期刊文献+

利多卡因用于经尿道膀胱肿瘤电切术患者神经刺激仪引导闭孔神经阻滞时的半数有效浓度 被引量:6

Median effective concentration of lidocaine for obturator nerve block guided by nerve stimulator in patients undergoing transurethral resection of bladder tumor
原文传递
导出
摘要 目的 确定利多卡因用于经尿道膀胱肿瘤电切术患者神经刺激仪引导闭孔神经阻滞时的半数有效浓度(EC50).方法 选择拟行经尿道膀胱肿瘤电切术的膀胱侧壁肿瘤患者,术前根据膀胱镜检或CT检查确定需行闭孔神经阻滞,ASA分级Ⅰ或Ⅱ级,体重指数19~30 kg/m2,年龄18~64岁,在神经刺激仪引导下经腹股沟上入路用利多卡因进行闭孔神经阻滞,利多卡因浓度根据序贯法确定,初始浓度为1.5%,相邻浓度之比为1.2.闭孔神经阻滞成功为阳性反应.计算利多卡因用于经尿道膀胱肿瘤电切术患者神经刺激仪引导闭孔神经阻滞时的EC50及其95%可信区间.结果 利多卡因用于经尿道膀胱肿瘤电切术患者神经刺激仪引导闭孔神经阻滞时的EC50为0.57%,95%可信区间为0.55% ~ 0.59%.结论 利多卡因用于经尿道膀胱肿瘤电切术患者神经刺激仪引导闭孔神经阻滞时的EC50为0.57%. Objective To determine the median effective concentration (EC50) of lidocaine for obturator nerve block (ONB) guided by a nerve stimulator in patients undergoing transurethral resection of bladder tumor (TURBT).Methods American Society of Anesthesiologists physical status Ⅰ or Ⅱ patients with bladder tumor,scheduled for elective TURBT,required ONB according to the results of cystoscopy or CT examination performed before operation,with body mass index of 19-30 kg/m2,aged 18-64 yr,were enrolled in the study.ONB was performed with lidocaine using the suprainguinal approach under the guidance of a nerve stimulator.The concentration of lidocaine was determined by up-and-down sequential trial.The initial concentration of lidocaine was 1.5%,and the ratio between the two successive concentrations was 1.2.Successful ONB was considered to be positive response.The EC50 and 95% confidence interval of lidocaine for ONB guided by a nerve stimulator was calculated.Results The EC50 of lidocaine was 0.57%,and the 95% confidence interval was 0.55%-0.59% when used for ONB guided by a nerve stimulator.Conclusion The EC50 of lidocaine is 0.57% when used for ONB guided by a nerve stimulator in the patients undergoing TURBT.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2016年第12期1480-1483,共4页 Chinese Journal of Anesthesiology
关键词 利多卡因 神经传导阻滞 闭孔神经 剂量效应关系 药物 Lidocaine Nerve block Obturator nerve Dose-response relationship,drug
  • 相关文献

参考文献1

二级参考文献8

  • 1薛昀,吴新民.靶控输注瑞芬太尼或芬太尼对术前病人异丙酚镇静作用的影响[J].中华麻醉学杂志,2005,25(10):729-732. 被引量:21
  • 2Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid:remifentanil (G187094B). Anesth Analg,1993, 77: 1031-1040.
  • 3Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999, 89 Suppl: s7-s14.
  • 4Jhavefi R, Joshi P, Batenhorst R, et al. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology, 1997, 87: 253-259.
  • 5Conway DH, Hasan SK, Simpson ME, et al. Target-contrelled propofol requirements at induction of anaesthesia: effect of remifentanil and midazolam.Eur J Anaestbesiol,2002.19:580-584.
  • 6Mertens MJ.Olofsen E.Enghers FH.et al.Propofol reduces perioperative remifentanil requirements in a synergiastic manner:response surface modeling of perioperative remifentanil-propofol interactions.Anesthesiology,2003.99:347-359.
  • 7Fragen RJ, Randel GI, Librojo ES, et al. The interaction of remifentanil and propofol to prevent response to tracheal intubation and the start of surgery for outpatient knee arthroscopy. Anesthesiology, 1994, 81:A376.
  • 8耿志宇,许幸,吴新民.瑞芬太尼复合异丙酚靶控输注诱导时的量效关系[J].中华麻醉学杂志,2004,24(4):260-263. 被引量:181

共引文献45

同被引文献47

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部